NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Free Cash Flow: -133.45M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -133.45M |
| September 30, 2023 | -141.15M |
| June 30, 2023 | -142.15M |
| March 31, 2023 | -152.77M |
| December 31, 2022 | -146.30M |
| September 30, 2022 | -133.92M |
| June 30, 2022 | -115.02M |
| March 31, 2022 | -88.55M |
| December 31, 2021 | -74.91M |
| September 30, 2021 | -76.76M |
| June 30, 2021 | -92.53M |
| Date | Value |
|---|---|
| March 31, 2021 | -88.08M |
| December 31, 2020 | -85.38M |
| September 30, 2020 | -80.72M |
| June 30, 2020 | -62.25M |
| March 31, 2020 | -50.47M |
| December 31, 2019 | -44.66M |
| September 30, 2019 | -22.10M |
| June 30, 2019 | -21.78M |
| March 31, 2019 | -21.81M |
| December 31, 2018 | -13.44M |
Free Cash Flow Range, Past 5 Years
-152.77M
Minimum
Mar 2023
-21.78M
Maximum
Jun 2019
-92.26M
Average
-88.08M
Median
Mar 2021
Free Cash Flow Benchmarks
| Catalent Inc | -123.00M |
| AIM ImmunoTech Inc | -23.04M |
| Perspective Therapeutics Inc | -23.28M |
| Protalix BioTherapeutics Inc | 4.369M |
| Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.96M |
| Cash from Investing (Quarterly) | 27.19M |
| Cash from Financing (Quarterly) | 0.111M |
| Free Cash Flow Per Share (Quarterly) | -0.2796 |
| Free Cash Flow to Equity (Quarterly) | -23.15M |
| Free Cash Flow Yield | -105.0% |